Ophthalmic Drug Discovery and Development: Regulatory Aspects of Patient Focused Drug Development in Ophthalmology View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2019-04

AUTHORS

Cheryl L. Rowe-Rendleman

ABSTRACT

In 2009, members of the ophthalmic research community held a joint meeting with members of the Food and Drug Administration (FDA) and the National Eye Institute (NEI) to define and describe the types of patient-focused drug development (PFDD) tools used in ophthalmology. Since then numerous reports have been published which indicate that many of the questionnaires used for patient-reported outcomes (PROs) in ophthalmic clinical development lack rigor and reliability according to modern methods. In 2017, the FDA began development of a series of four methodological guidances for sponsors of clinical trials on the significance of PFDD. The new guidances delineate the FDA's thinking and commitments under the Prescription Drug User Fee Act to implement a more structured approach to the assessment of risks and benefits in clinical trials. In these guidances, the FDA provides steps that drug and device manufacturers should follow, not only to obtain, but also to develop reliable and validated tools that measure patients' experience in clinical trials. Subsequent efforts have resulted in the development and validation of PROs specifically for ophthalmology. The purpose of this paper is to assesses the PROs currently used in ophthalmology and to provide practical strategies for incorporating them into clinical trials. More... »

PAGES

54

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s11095-019-2577-8

DOI

http://dx.doi.org/10.1007/s11095-019-2577-8

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1112305511

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30790065


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Administration, Ophthalmic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Clinical Trials as Topic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Approval", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Compounding", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Development", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Discovery", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Endpoint Determination", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Eye", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Eye Diseases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Government Regulation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ocular Absorption", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ophthalmic Solutions", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Patient Reported Outcome Measures", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Patient Safety", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Psychometrics", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Assessment", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "United States", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "United States Food and Drug Administration", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "Ophthalmic Medical and Research Consulting, Omar Consulting Group, LLC, 08550, Princeton Junction, NJ, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rowe-Rendleman", 
        "givenName": "Cheryl L.", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1167/iovs.05-1222", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001512631"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1008996223999", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002685260", 
          "https://doi.org/10.1023/a:1008996223999"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/ard.2010.143743", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003044413"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ophtha.2016.03.045", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005909588"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ophtha.2015.02.037", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007277525"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1167/iovs.09-4494", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007961610"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.survophthal.2016.12.011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008324392"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ajo.2007.06.012", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012051785"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1167/iovs.11-7858", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014077478"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.5116/ijme.4dfb.8dfd", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015632748"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ophtha.2008.10.018", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016827406"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1102673", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018732383"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ophtha.2012.03.053", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018935436"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jcrs.2008.11.038", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020450222"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1207/s15327752jpa8502_02", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025275661"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1207/s15327752jpa8502_02", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025275661"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2147/ppa.s105536", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025433022"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ophtha.2011.12.016", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028796676"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1167/iovs.10-5627", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031778992"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jcrs.2009.11.019", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031913828"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.phrs.2015.11.027", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033277304"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/ico.0000000000000038", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034919273"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/ico.0000000000000038", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034919273"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1542-0124(12)70081-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040875997"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/archopht.118.5.615", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041238167"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa054481", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041610759"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jtos.2012.01.007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042444231"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(13)61501-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043271928"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bjophthalmol-2014-306544", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043598506"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/eye.2014.41", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045327865", 
          "https://doi.org/10.1038/eye.2014.41"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/opx.0000000000000913", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046741348"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/opx.0000000000000913", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046741348"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jamaophthalmol.2016.2101", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049230263"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1167/iovs.07-0290", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050790918"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/archopht.119.7.1050", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052734113"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/13548506.2016.1274040", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1058383148"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ajo.2017.03.009", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1084056752"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1167/tvst.6.3.12", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1085705016"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmjopen-2017-018166", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1101034366"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmjopen-2017-018166", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1101034366"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmjopen-2017-018166", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1101034366"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.oret.2018.01.006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1101289679"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2147/ppa.s168921", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1106362561"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jtos.2018.11.003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1109779954"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-04", 
    "datePublishedReg": "2019-04-01", 
    "description": "In 2009, members of the ophthalmic research community held a joint meeting with members of the Food and Drug Administration (FDA) and the National Eye Institute (NEI) to define and describe the types of patient-focused drug development (PFDD) tools used in ophthalmology. Since then numerous reports have been published which indicate that many of the questionnaires used for patient-reported outcomes (PROs) in ophthalmic clinical development lack rigor and reliability according to modern methods. In 2017, the FDA began development of a series of four methodological guidances for sponsors of clinical trials on the significance of PFDD. The new guidances delineate the FDA's thinking and commitments under the Prescription Drug User Fee Act to implement a more structured approach to the assessment of risks and benefits in clinical trials. In these guidances, the FDA provides steps that drug and device manufacturers should follow, not only to obtain, but also to develop reliable and validated tools that measure patients' experience in clinical trials. Subsequent efforts have resulted in the development and validation of PROs specifically for ophthalmology. The purpose of this paper is to assesses the PROs currently used in ophthalmology and to provide practical strategies for incorporating them into clinical trials.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s11095-019-2577-8", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1094644", 
        "issn": [
          "0724-8741", 
          "1573-904X"
        ], 
        "name": "Pharmaceutical Research", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "36"
      }
    ], 
    "name": "Ophthalmic Drug Discovery and Development: Regulatory Aspects of Patient Focused Drug Development in Ophthalmology", 
    "pagination": "54", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "0b87970633fba698437ae88bd95891a05934e2c1264a0d80b425fd5855d46548"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30790065"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8406521"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s11095-019-2577-8"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1112305511"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s11095-019-2577-8", 
      "https://app.dimensions.ai/details/publication/pub.1112305511"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T12:55", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000364_0000000364/records_72867_00000001.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1007%2Fs11095-019-2577-8"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11095-019-2577-8'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11095-019-2577-8'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11095-019-2577-8'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11095-019-2577-8'


 

This table displays all metadata directly associated to this object as RDF triples.

266 TRIPLES      21 PREDICATES      88 URIs      41 LITERALS      29 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s11095-019-2577-8 schema:about N02acfebcfa0f4e088211b2ca64d82aea
2 N0731e3d4ec63451e932f94080cfeeec2
3 N10de179ad5b54eab8e3b9a622c537fee
4 N12ce55d9e24f4c8b924d90a5a0d0e6c3
5 N1538dc66c1d041b8909996c1d98dba96
6 N2309b03e129540129f0f786d8e2b8bb5
7 N2a0a4cfe85784c6bb96eaaa9ccf74dfb
8 N2aabb8ac79a3431b985302abdfe3739c
9 N49f0609b9c7b4dafb15259abdf7fd0fa
10 N519518fa28644d4685a502227eb2ac1e
11 N52e5c41072064d32a27baeb32de595b6
12 N6e5d9fd1553c459183f9ab3125a1eb0b
13 N779bd40c674946aebff72c30786099c7
14 Nb25cab5c0c414752b0da3db9a7c3e974
15 Nb5b731372918457586ff0c19e0139d08
16 Ne38bb3de38ff4b9e886cab48b92a9303
17 Nea0cd7cd877d4f01b856a0da6d92677a
18 Neacf737b217c4abf9fe5f9cb18cccfdd
19 Nfe52cedb74d24022a2d1903cc9ce03fe
20 Nfe75d5a1924d4fafb6bb791251fe3d2a
21 anzsrc-for:11
22 anzsrc-for:1117
23 schema:author Nea6939fee5d4422ead858570a7411b0d
24 schema:citation sg:pub.10.1023/a:1008996223999
25 sg:pub.10.1038/eye.2014.41
26 https://doi.org/10.1001/archopht.118.5.615
27 https://doi.org/10.1001/archopht.119.7.1050
28 https://doi.org/10.1001/jamaophthalmol.2016.2101
29 https://doi.org/10.1016/j.ajo.2007.06.012
30 https://doi.org/10.1016/j.ajo.2017.03.009
31 https://doi.org/10.1016/j.jcrs.2008.11.038
32 https://doi.org/10.1016/j.jcrs.2009.11.019
33 https://doi.org/10.1016/j.jtos.2012.01.007
34 https://doi.org/10.1016/j.jtos.2018.11.003
35 https://doi.org/10.1016/j.ophtha.2008.10.018
36 https://doi.org/10.1016/j.ophtha.2011.12.016
37 https://doi.org/10.1016/j.ophtha.2012.03.053
38 https://doi.org/10.1016/j.ophtha.2015.02.037
39 https://doi.org/10.1016/j.ophtha.2016.03.045
40 https://doi.org/10.1016/j.oret.2018.01.006
41 https://doi.org/10.1016/j.phrs.2015.11.027
42 https://doi.org/10.1016/j.survophthal.2016.12.011
43 https://doi.org/10.1016/s0140-6736(13)61501-9
44 https://doi.org/10.1016/s1542-0124(12)70081-2
45 https://doi.org/10.1056/nejmoa054481
46 https://doi.org/10.1056/nejmoa1102673
47 https://doi.org/10.1080/13548506.2016.1274040
48 https://doi.org/10.1097/ico.0000000000000038
49 https://doi.org/10.1097/opx.0000000000000913
50 https://doi.org/10.1136/ard.2010.143743
51 https://doi.org/10.1136/bjophthalmol-2014-306544
52 https://doi.org/10.1136/bmjopen-2017-018166
53 https://doi.org/10.1167/iovs.05-1222
54 https://doi.org/10.1167/iovs.07-0290
55 https://doi.org/10.1167/iovs.09-4494
56 https://doi.org/10.1167/iovs.10-5627
57 https://doi.org/10.1167/iovs.11-7858
58 https://doi.org/10.1167/tvst.6.3.12
59 https://doi.org/10.1207/s15327752jpa8502_02
60 https://doi.org/10.2147/ppa.s105536
61 https://doi.org/10.2147/ppa.s168921
62 https://doi.org/10.5116/ijme.4dfb.8dfd
63 schema:datePublished 2019-04
64 schema:datePublishedReg 2019-04-01
65 schema:description In 2009, members of the ophthalmic research community held a joint meeting with members of the Food and Drug Administration (FDA) and the National Eye Institute (NEI) to define and describe the types of patient-focused drug development (PFDD) tools used in ophthalmology. Since then numerous reports have been published which indicate that many of the questionnaires used for patient-reported outcomes (PROs) in ophthalmic clinical development lack rigor and reliability according to modern methods. In 2017, the FDA began development of a series of four methodological guidances for sponsors of clinical trials on the significance of PFDD. The new guidances delineate the FDA's thinking and commitments under the Prescription Drug User Fee Act to implement a more structured approach to the assessment of risks and benefits in clinical trials. In these guidances, the FDA provides steps that drug and device manufacturers should follow, not only to obtain, but also to develop reliable and validated tools that measure patients' experience in clinical trials. Subsequent efforts have resulted in the development and validation of PROs specifically for ophthalmology. The purpose of this paper is to assesses the PROs currently used in ophthalmology and to provide practical strategies for incorporating them into clinical trials.
66 schema:genre research_article
67 schema:inLanguage en
68 schema:isAccessibleForFree false
69 schema:isPartOf Na38db70444454d5092f475830328fcf2
70 Nebe2431ae7014c628fd48a24d4a353bb
71 sg:journal.1094644
72 schema:name Ophthalmic Drug Discovery and Development: Regulatory Aspects of Patient Focused Drug Development in Ophthalmology
73 schema:pagination 54
74 schema:productId N07248ca331a6409c87fa2ebf71a7b055
75 N57b4f918e4a04f79ab305801d5000d2a
76 N5f70534ae1c940fea0dd6ca99ba07bf0
77 N8d6dd93233904f8eb73d8ee142553b77
78 Ne3588ff11c0846d1bd8640e933161574
79 schema:sameAs https://app.dimensions.ai/details/publication/pub.1112305511
80 https://doi.org/10.1007/s11095-019-2577-8
81 schema:sdDatePublished 2019-04-11T12:55
82 schema:sdLicense https://scigraph.springernature.com/explorer/license/
83 schema:sdPublisher N9ae44013f29d47e98a9b217b4fbeb592
84 schema:url https://link.springer.com/10.1007%2Fs11095-019-2577-8
85 sgo:license sg:explorer/license/
86 sgo:sdDataset articles
87 rdf:type schema:ScholarlyArticle
88 N02acfebcfa0f4e088211b2ca64d82aea schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
89 schema:name Eye Diseases
90 rdf:type schema:DefinedTerm
91 N07248ca331a6409c87fa2ebf71a7b055 schema:name doi
92 schema:value 10.1007/s11095-019-2577-8
93 rdf:type schema:PropertyValue
94 N0731e3d4ec63451e932f94080cfeeec2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Endpoint Determination
96 rdf:type schema:DefinedTerm
97 N10de179ad5b54eab8e3b9a622c537fee schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Psychometrics
99 rdf:type schema:DefinedTerm
100 N12ce55d9e24f4c8b924d90a5a0d0e6c3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Drug Development
102 rdf:type schema:DefinedTerm
103 N1538dc66c1d041b8909996c1d98dba96 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Humans
105 rdf:type schema:DefinedTerm
106 N2309b03e129540129f0f786d8e2b8bb5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Patient Safety
108 rdf:type schema:DefinedTerm
109 N2a0a4cfe85784c6bb96eaaa9ccf74dfb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Drug Approval
111 rdf:type schema:DefinedTerm
112 N2aabb8ac79a3431b985302abdfe3739c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name United States
114 rdf:type schema:DefinedTerm
115 N3e89e6cab4444029af8b45b43d12ab3a schema:affiliation Nd98e964a17fd466b83c5c5664c457f85
116 schema:familyName Rowe-Rendleman
117 schema:givenName Cheryl L.
118 rdf:type schema:Person
119 N49f0609b9c7b4dafb15259abdf7fd0fa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Ocular Absorption
121 rdf:type schema:DefinedTerm
122 N519518fa28644d4685a502227eb2ac1e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Clinical Trials as Topic
124 rdf:type schema:DefinedTerm
125 N52e5c41072064d32a27baeb32de595b6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Drug Compounding
127 rdf:type schema:DefinedTerm
128 N57b4f918e4a04f79ab305801d5000d2a schema:name dimensions_id
129 schema:value pub.1112305511
130 rdf:type schema:PropertyValue
131 N5f70534ae1c940fea0dd6ca99ba07bf0 schema:name pubmed_id
132 schema:value 30790065
133 rdf:type schema:PropertyValue
134 N6e5d9fd1553c459183f9ab3125a1eb0b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Treatment Outcome
136 rdf:type schema:DefinedTerm
137 N779bd40c674946aebff72c30786099c7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Patient Reported Outcome Measures
139 rdf:type schema:DefinedTerm
140 N8d6dd93233904f8eb73d8ee142553b77 schema:name readcube_id
141 schema:value 0b87970633fba698437ae88bd95891a05934e2c1264a0d80b425fd5855d46548
142 rdf:type schema:PropertyValue
143 N9ae44013f29d47e98a9b217b4fbeb592 schema:name Springer Nature - SN SciGraph project
144 rdf:type schema:Organization
145 Na38db70444454d5092f475830328fcf2 schema:volumeNumber 36
146 rdf:type schema:PublicationVolume
147 Nb25cab5c0c414752b0da3db9a7c3e974 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Risk Assessment
149 rdf:type schema:DefinedTerm
150 Nb5b731372918457586ff0c19e0139d08 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Government Regulation
152 rdf:type schema:DefinedTerm
153 Nd98e964a17fd466b83c5c5664c457f85 schema:name Ophthalmic Medical and Research Consulting, Omar Consulting Group, LLC, 08550, Princeton Junction, NJ, USA
154 rdf:type schema:Organization
155 Ne3588ff11c0846d1bd8640e933161574 schema:name nlm_unique_id
156 schema:value 8406521
157 rdf:type schema:PropertyValue
158 Ne38bb3de38ff4b9e886cab48b92a9303 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Ophthalmic Solutions
160 rdf:type schema:DefinedTerm
161 Nea0cd7cd877d4f01b856a0da6d92677a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Administration, Ophthalmic
163 rdf:type schema:DefinedTerm
164 Nea6939fee5d4422ead858570a7411b0d rdf:first N3e89e6cab4444029af8b45b43d12ab3a
165 rdf:rest rdf:nil
166 Neacf737b217c4abf9fe5f9cb18cccfdd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Eye
168 rdf:type schema:DefinedTerm
169 Nebe2431ae7014c628fd48a24d4a353bb schema:issueNumber 4
170 rdf:type schema:PublicationIssue
171 Nfe52cedb74d24022a2d1903cc9ce03fe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name United States Food and Drug Administration
173 rdf:type schema:DefinedTerm
174 Nfe75d5a1924d4fafb6bb791251fe3d2a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
175 schema:name Drug Discovery
176 rdf:type schema:DefinedTerm
177 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
178 schema:name Medical and Health Sciences
179 rdf:type schema:DefinedTerm
180 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
181 schema:name Public Health and Health Services
182 rdf:type schema:DefinedTerm
183 sg:journal.1094644 schema:issn 0724-8741
184 1573-904X
185 schema:name Pharmaceutical Research
186 rdf:type schema:Periodical
187 sg:pub.10.1023/a:1008996223999 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002685260
188 https://doi.org/10.1023/a:1008996223999
189 rdf:type schema:CreativeWork
190 sg:pub.10.1038/eye.2014.41 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045327865
191 https://doi.org/10.1038/eye.2014.41
192 rdf:type schema:CreativeWork
193 https://doi.org/10.1001/archopht.118.5.615 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041238167
194 rdf:type schema:CreativeWork
195 https://doi.org/10.1001/archopht.119.7.1050 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052734113
196 rdf:type schema:CreativeWork
197 https://doi.org/10.1001/jamaophthalmol.2016.2101 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049230263
198 rdf:type schema:CreativeWork
199 https://doi.org/10.1016/j.ajo.2007.06.012 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012051785
200 rdf:type schema:CreativeWork
201 https://doi.org/10.1016/j.ajo.2017.03.009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1084056752
202 rdf:type schema:CreativeWork
203 https://doi.org/10.1016/j.jcrs.2008.11.038 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020450222
204 rdf:type schema:CreativeWork
205 https://doi.org/10.1016/j.jcrs.2009.11.019 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031913828
206 rdf:type schema:CreativeWork
207 https://doi.org/10.1016/j.jtos.2012.01.007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042444231
208 rdf:type schema:CreativeWork
209 https://doi.org/10.1016/j.jtos.2018.11.003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1109779954
210 rdf:type schema:CreativeWork
211 https://doi.org/10.1016/j.ophtha.2008.10.018 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016827406
212 rdf:type schema:CreativeWork
213 https://doi.org/10.1016/j.ophtha.2011.12.016 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028796676
214 rdf:type schema:CreativeWork
215 https://doi.org/10.1016/j.ophtha.2012.03.053 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018935436
216 rdf:type schema:CreativeWork
217 https://doi.org/10.1016/j.ophtha.2015.02.037 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007277525
218 rdf:type schema:CreativeWork
219 https://doi.org/10.1016/j.ophtha.2016.03.045 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005909588
220 rdf:type schema:CreativeWork
221 https://doi.org/10.1016/j.oret.2018.01.006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1101289679
222 rdf:type schema:CreativeWork
223 https://doi.org/10.1016/j.phrs.2015.11.027 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033277304
224 rdf:type schema:CreativeWork
225 https://doi.org/10.1016/j.survophthal.2016.12.011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008324392
226 rdf:type schema:CreativeWork
227 https://doi.org/10.1016/s0140-6736(13)61501-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043271928
228 rdf:type schema:CreativeWork
229 https://doi.org/10.1016/s1542-0124(12)70081-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040875997
230 rdf:type schema:CreativeWork
231 https://doi.org/10.1056/nejmoa054481 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041610759
232 rdf:type schema:CreativeWork
233 https://doi.org/10.1056/nejmoa1102673 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018732383
234 rdf:type schema:CreativeWork
235 https://doi.org/10.1080/13548506.2016.1274040 schema:sameAs https://app.dimensions.ai/details/publication/pub.1058383148
236 rdf:type schema:CreativeWork
237 https://doi.org/10.1097/ico.0000000000000038 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034919273
238 rdf:type schema:CreativeWork
239 https://doi.org/10.1097/opx.0000000000000913 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046741348
240 rdf:type schema:CreativeWork
241 https://doi.org/10.1136/ard.2010.143743 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003044413
242 rdf:type schema:CreativeWork
243 https://doi.org/10.1136/bjophthalmol-2014-306544 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043598506
244 rdf:type schema:CreativeWork
245 https://doi.org/10.1136/bmjopen-2017-018166 schema:sameAs https://app.dimensions.ai/details/publication/pub.1101034366
246 rdf:type schema:CreativeWork
247 https://doi.org/10.1167/iovs.05-1222 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001512631
248 rdf:type schema:CreativeWork
249 https://doi.org/10.1167/iovs.07-0290 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050790918
250 rdf:type schema:CreativeWork
251 https://doi.org/10.1167/iovs.09-4494 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007961610
252 rdf:type schema:CreativeWork
253 https://doi.org/10.1167/iovs.10-5627 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031778992
254 rdf:type schema:CreativeWork
255 https://doi.org/10.1167/iovs.11-7858 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014077478
256 rdf:type schema:CreativeWork
257 https://doi.org/10.1167/tvst.6.3.12 schema:sameAs https://app.dimensions.ai/details/publication/pub.1085705016
258 rdf:type schema:CreativeWork
259 https://doi.org/10.1207/s15327752jpa8502_02 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025275661
260 rdf:type schema:CreativeWork
261 https://doi.org/10.2147/ppa.s105536 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025433022
262 rdf:type schema:CreativeWork
263 https://doi.org/10.2147/ppa.s168921 schema:sameAs https://app.dimensions.ai/details/publication/pub.1106362561
264 rdf:type schema:CreativeWork
265 https://doi.org/10.5116/ijme.4dfb.8dfd schema:sameAs https://app.dimensions.ai/details/publication/pub.1015632748
266 rdf:type schema:CreativeWork
 




Preview window. Press ESC to close (or click here)


...